|
Disease |
Agent |
Characteristics |
|
Bacterial
urogenital diseases |
|
|
|
Urinary tract infections |
E. coli, Proteus mirabilis |
Dysuria; sometimes leads to chronic cystitis; often ascend or descend in urinary tract |
|
Prostatitis |
E. coli and other bacterial species |
Dysuria, urgent and frequent urination, low fever, back pain; can cause infertility |
|
Pyelonephritis |
E. coli and other bacterial species, sometimes the yeast Candida |
Inflammation of pelvis of kidney, urinary tract blockage; dysuria, nocturia, fever |
|
Glomerulonephritis |
Streptococcal or viral infections from other sites |
Deposition of immune complexes causes inflammation of glomeruli; can cause permanent kidney damage |
|
Leptospirosis |
Leptospira interrognas |
Fever, nonspecific symptoms; can lead to Weil's syndrome w/jaundice and liver damage |
|
Bacterial vaginitis |
Gardenerella vaginalis w/anaerobes |
Frothy, fishy-smelling discharge, pain and inflammation |
|
Toxic shock syndrome |
Staphylococcus aureus |
Toxins reach blood and cause fever, rash, and shock that can lead to death |
|
Parasitic
urogenital disease |
|
|
|
Trichomoniasis |
Tichomonas vaginalis |
Intense itching, copious white discharge |
|
Bacterial sexually
transmitted diseases |
|
|
|
Gonorhea |
Neisseria gonorrhoeae |
Infectious organisms release endotoxin that damages mucosa; pus-filled discharge; can cause PID and infect other systems |
|
Syphilis |
Treponema pallidum |
Chancre develops in 1° stage; mucous membrane lesions and rash occur in 2° stage; permanent cardiovascular and neurological damage often occur in3° |
|
Chancroid |
Haemophilus ducreyi |
Painful, bleeding lesions on genitals; often enlarge lymphatic buboes |
|
Nongonococcal urethritis |
Chlamdia trachomatis and mycoplasmas |
Scanty water urethral discharge, inflammation, sometimes sterility; can cause neonatal infections and fetal death |
|
Lymphogranuloma venereum |
Chlamydia trachomatis |
Genital lesions, fever, malaise, headache, nausea, vomiting, skin rash; lymph nodes become pus-filled buboes |
|
Granuloma inguinale |
Calymmatobacterium granulomatis |
Painful ulcers on genitals and other sites; loss of skin pigmentation as ulcers heal |
|
Viral sexually
trasmitted diseases |
|
|
|
Herpes simplex infections |
Herpes simplex viruses |
Fever blisters usually caused by HSV-1, genital herpes usually caused by HSV-2 (both are latent viruses); recurrent painful vesicular lesions, neonatal herpes and a variety of other manifestations |
|
Genital warts |
Human papillomaviruses |
Warts on genitals, vagina, and cervix; irritation and sometimes intense itching; can contribute to cervical carcinoma |
|
Cytomegalovirus infections |
Cytomegaloviruses |
Often asymptomatic but severe in fetuses, neonates, and immunodeficient patients; malaise, myalgia, fever, inflamed lymph nodes, neural damage and death in fetuses and neonates |
Representative antibacterial substances in animal tissues and/or fluids
|
Substance |
Common Sources |
General Chemical Composition |
Types of Microorganisms Affected |
|
Complement |
Sera of most warm blooded animals |
Believed to be a protein-CHO lipoprotein complex |
Gram negative |
|
Histone |
Components of the lymphatic system |
Protein (sulfur containing) |
Gram positive |
|
Interferon |
Virus-infected cells |
Protein |
Various viruses and certain protozoa |
|
Leukin |
Leukoctes |
Basic peptides (protein like) |
Gram positives |
|
Lysozyme |
Include leukocytes, saliva, perspiration, tears, egg whites |
Protein |
Mainly gram positives |
|
Phagocytin |
Leukocytes |
Protein |
Gram negative |
|
Properdin |
Serum |
Protein |
Gram negative and certain viruses |
|
Protamine |
Spermatozoa |
Protein |
Gram positive |
|
Spermidine, spermine |
Prostate and pancreas |
Basic polyamines |
Gram positives |
|
Tissue polypeptides |
Components of the lymphatic system |
Basic peptides |
Gram positives |
|
Opsonin |
Lymphatic system |
Protein is not an antibody but its concentration increases w/immunization |
Make palatable (digestible) by macrophages |
Formed Elements of the Blood in Healthy Adults
|
Element |
Normal numbers (/ mL) |
Life span |
Functions |
|
Erythrocytes |
|
120 days |
Transport oxygen gas from lungs to tissues; transport CO2 gas from tissues to lungs |
|
Adult male |
4.6-6.2 million |
|
|
|
Adult female |
4.2-5.4 million |
|
|
|
Newborn |
5.0-5.1 million |
|
|
|
Leukocytes |
5000-9000 |
Hours to days |
|
|
Granulocytes |
|
|
|
|
Neutrophils |
50-70% |
|
Phagocytic; contain oxidative chemicals to kill internalized microbes |
|
Eosinophils |
1-5% |
|
Release defensive chemicals to damage parasites (worms); phagocytic |
|
Basophils |
0.1% |
|
Release histamine and other chemicals during inflammation; responsible for allergic symptoms |
Agranulocytes |
|
|
|
|
Monocytes |
2-8% |
|
In tissues, develop into macrophages, which are phagocytic |
|
Lymphocytes |
20-40% |
|
Essential to specific host immune defenses; antibody production |
|
Platelets |
250,000-300,000 |
5-9 days |
Blood clotting |
Nonspecific defenses
|
Physical barriers—prevent approach and deny access to pathogens |
· Hair · Secretions · Epithelium |
|
Phagocytes—remove debris and pathogens |
· Fixed macrophages · Neutrophil · Free macrophage · Eosinophil · Monocyte |
|
Extracellular killing—destroys abnormal cells |
Natural killer cell®abnormal cells®lysed abnormal cell |
|
Inflammatory response—multiple effects |
1. Blood flow increased 2. Phagocytes activated 3. Capillary permeability increased 4. Complement activated 5. Clotting reaction walls off region 6. Regional temperature increased 7. Specific defenses activated |
|
Fever—mobilizes defenses, accelerates repairs, inhibits pathogens |
Body temperature rises above 37°C in response to pyrogens |
|
Interferons—increase resistance of cells to infection, slow the spread of disease |
Released by activated lymphocytes and macrophages and by virus-infected cells |
|
Complement system—attacks and breaks down cell walls, attracts phagocytes, stimulates inflammation |
complement®surrounds the microbe®lysed pathogen |
Properties of Immunoglobulins
|
Property |
IgG |
IgM |
IgA |
IgE |
IgD |
|
Number of units |
1 |
5 |
1 or 2 |
1 |
1 |
|
Activation of complement |
Yes |
Yes, strongly |
Yes, by alternative pathway |
No |
No |
|
Crosses placenta |
Yes |
No |
No |
No |
No |
|
Binds to phagocytes |
Yes |
No |
No |
No |
No |
|
Binds to lymphocytes |
Yes |
Yes |
Yes |
Yes |
No |
|
Binds to mast cells and basophils |
No |
No |
No |
Yes |
No |
|
½ life (days) in serum |
21 |
10 |
6 |
2 |
3 |
|
% of total blood antibodies in serum |
75% |
10% |
10% |
0.005% |
0.2% |
|
Location |
Serum, extravascular, and across placenta |
Serum and B cell membrane |
Transport across epithelium |
Serum and extravascular |
B cell membrane |
Characteristics of B cells, T cells, and macrophages
|
Characteristic |
B cells |
T cells |
Macrophages |
|
Site of production |
Bone marrow |
Thymus or under thymic hormones |
|
|
Type of immunity |
Humoral |
Cell-mediated; assist in humoral |
Humoral and cell-mediated |
|
Subpopulation |
Plasma cells and memory cells |
Cytotoxic, helper, and memory cells |
Fixed and wandering |
|
Presence of surface antibodies |
Yes |
No |
No |
|
Presence of foreign surface antigens |
Yes |
No |
Yes |
|
Presence of receptors for antigens |
Yes |
Yes |
No |
|
Life span |
Memory cells: years Others: days or wks |
Years |
Years |
|
Secretory product |
Antibodies |
Cytokines |
Cytokines |
|
Distribution (% leukocytes) |
|
|
|
|
Peripheral blood |
15-30 |
55-75 |
2-12 |
|
Lymph nodes |
20 |
75 |
5 |
|
Bone marrow |
75 |
10 |
10-15 |
|
Thymus |
10 |
75 |
10 |